Global Anti-PD-1 Antibody Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Anti-PD-1 Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Anti-PD-1 Antibody market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. IHC-P accounting for % of the Anti-PD-1 Antibody global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monoclonal segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anti-PD-1 Antibody include Bio X Cell, Thermo Fisher, InvivoGen, BioVision Inc, and Abcam, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anti-PD-1 Antibody market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal
Polyclonal
Market segment by Application can be divided into
IHC-P
ICC/IF
WB
Flow Cytometry
ELISA
The key market players for global Anti-PD-1 Antibody market are listed below:
Bio X Cell
Thermo Fisher
InvivoGen
BioVision Inc
Abcam
Bristol-Myers Squibb (BMS)
Merck
Ono Pharmaceutical Co., Ltd
Lilly
Chugai Pharmaceutical Co., Ltd
BeiGene
Abbvie
TG Therapeutics, Inc
Novartis
Arcus Biosciences
Sino Biological Inc
3SBio Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-PD-1 Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-PD-1 Antibody, with price, sales, revenue and global market share of Anti-PD-1 Antibody from 2019 to 2022.
Chapter 3, the Anti-PD-1 Antibody competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-PD-1 Antibody breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anti-PD-1 Antibody market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-PD-1 Antibody.
Chapter 13, 14, and 15, to describe Anti-PD-1 Antibody sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Anti-PD-1 Antibody Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-PD-1 Antibody Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-PD-1 Antibody Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 IHC-P
1.3.3 ICC/IF
1.3.4 WB
1.3.5 Flow Cytometry
1.3.6 ELISA
1.4 Global Anti-PD-1 Antibody Market Size & Forecast
1.4.1 Global Anti-PD-1 Antibody Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anti-PD-1 Antibody Sales in Volume (2017-2028)
1.4.3 Global Anti-PD-1 Antibody Price (2017-2028)
1.5 Global Anti-PD-1 Antibody Production Capacity Analysis
1.5.1 Global Anti-PD-1 Antibody Total Production Capacity (2017-2028)
1.5.2 Global Anti-PD-1 Antibody Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-PD-1 Antibody Market Drivers
1.6.2 Anti-PD-1 Antibody Market Restraints
1.6.3 Anti-PD-1 Antibody Trends Analysis
2 Manufacturers Profiles
2.1 Bio X Cell
2.1.1 Bio X Cell Details
2.1.2 Bio X Cell Major Business
2.1.3 Bio X Cell Anti-PD-1 Antibody Product and Services
2.1.4 Bio X Cell Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Thermo Fisher
2.2.1 Thermo Fisher Details
2.2.2 Thermo Fisher Major Business
2.2.3 Thermo Fisher Anti-PD-1 Antibody Product and Services
2.2.4 Thermo Fisher Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 InvivoGen
2.3.1 InvivoGen Details
2.3.2 InvivoGen Major Business
2.3.3 InvivoGen Anti-PD-1 Antibody Product and Services
2.3.4 InvivoGen Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 BioVision Inc
2.4.1 BioVision Inc Details
2.4.2 BioVision Inc Major Business
2.4.3 BioVision Inc Anti-PD-1 Antibody Product and Services
2.4.4 BioVision Inc Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Abcam
2.5.1 Abcam Details
2.5.2 Abcam Major Business
2.5.3 Abcam Anti-PD-1 Antibody Product and Services
2.5.4 Abcam Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bristol-Myers Squibb (BMS)
2.6.1 Bristol-Myers Squibb (BMS) Details
2.6.2 Bristol-Myers Squibb (BMS) Major Business
2.6.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product and Services
2.6.4 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Anti-PD-1 Antibody Product and Services
2.7.4 Merck Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Ono Pharmaceutical Co., Ltd
2.8.1 Ono Pharmaceutical Co., Ltd Details
2.8.2 Ono Pharmaceutical Co., Ltd Major Business
2.8.3 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product and Services
2.8.4 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Lilly
2.9.1 Lilly Details
2.9.2 Lilly Major Business
2.9.3 Lilly Anti-PD-1 Antibody Product and Services
2.9.4 Lilly Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Chugai Pharmaceutical Co., Ltd
2.10.1 Chugai Pharmaceutical Co., Ltd Details
2.10.2 Chugai Pharmaceutical Co., Ltd Major Business
2.10.3 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product and Services
2.10.4 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 BeiGene
2.11.1 BeiGene Details
2.11.2 BeiGene Major Business
2.11.3 BeiGene Anti-PD-1 Antibody Product and Services
2.11.4 BeiGene Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Abbvie
2.12.1 Abbvie Details
2.12.2 Abbvie Major Business
2.12.3 Abbvie Anti-PD-1 Antibody Product and Services
2.12.4 Abbvie Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 TG Therapeutics, Inc
2.13.1 TG Therapeutics, Inc Details
2.13.2 TG Therapeutics, Inc Major Business
2.13.3 TG Therapeutics, Inc Anti-PD-1 Antibody Product and Services
2.13.4 TG Therapeutics, Inc Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Novartis
2.14.1 Novartis Details
2.14.2 Novartis Major Business
2.14.3 Novartis Anti-PD-1 Antibody Product and Services
2.14.4 Novartis Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Arcus Biosciences
2.15.1 Arcus Biosciences Details
2.15.2 Arcus Biosciences Major Business
2.15.3 Arcus Biosciences Anti-PD-1 Antibody Product and Services
2.15.4 Arcus Biosciences Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Sino Biological Inc
2.16.1 Sino Biological Inc Details
2.16.2 Sino Biological Inc Major Business
2.16.3 Sino Biological Inc Anti-PD-1 Antibody Product and Services
2.16.4 Sino Biological Inc Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 3SBio Inc
2.17.1 3SBio Inc Details
2.17.2 3SBio Inc Major Business
2.17.3 3SBio Inc Anti-PD-1 Antibody Product and Services
2.17.4 3SBio Inc Anti-PD-1 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anti-PD-1 Antibody Breakdown Data by Manufacturer
3.1 Global Anti-PD-1 Antibody Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anti-PD-1 Antibody Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anti-PD-1 Antibody
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-PD-1 Antibody Manufacturer Market Share in 2021
3.4.2 Top 6 Anti-PD-1 Antibody Manufacturer Market Share in 2021
3.5 Global Anti-PD-1 Antibody Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anti-PD-1 Antibody Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-PD-1 Antibody Market Size by Region
4.1.1 Global Anti-PD-1 Antibody Sales in Volume by Region (2017-2028)
4.1.2 Global Anti-PD-1 Antibody Revenue by Region (2017-2028)
4.2 North America Anti-PD-1 Antibody Revenue (2017-2028)
4.3 Europe Anti-PD-1 Antibody Revenue (2017-2028)
4.4 Asia-Pacific Anti-PD-1 Antibody Revenue (2017-2028)
4.5 South America Anti-PD-1 Antibody Revenue (2017-2028)
4.6 Middle East and Africa Anti-PD-1 Antibody Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anti-PD-1 Antibody Sales in Volume by Type (2017-2028)
5.2 Global Anti-PD-1 Antibody Revenue by Type (2017-2028)
5.3 Global Anti-PD-1 Antibody Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anti-PD-1 Antibody Sales in Volume by Application (2017-2028)
6.2 Global Anti-PD-1 Antibody Revenue by Application (2017-2028)
6.3 Global Anti-PD-1 Antibody Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anti-PD-1 Antibody Sales by Type (2017-2028)
7.2 North America Anti-PD-1 Antibody Sales by Application (2017-2028)
7.3 North America Anti-PD-1 Antibody Market Size by Country
7.3.1 North America Anti-PD-1 Antibody Sales in Volume by Country (2017-2028)
7.3.2 North America Anti-PD-1 Antibody Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-PD-1 Antibody Sales by Type (2017-2028)
8.2 Europe Anti-PD-1 Antibody Sales by Application (2017-2028)
8.3 Europe Anti-PD-1 Antibody Market Size by Country
8.3.1 Europe Anti-PD-1 Antibody Sales in Volume by Country (2017-2028)
8.3.2 Europe Anti-PD-1 Antibody Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anti-PD-1 Antibody Sales by Type (2017-2028)
9.2 Asia-Pacific Anti-PD-1 Antibody Sales by Application (2017-2028)
9.3 Asia-Pacific Anti-PD-1 Antibody Market Size by Region
9.3.1 Asia-Pacific Anti-PD-1 Antibody Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anti-PD-1 Antibody Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anti-PD-1 Antibody Sales by Type (2017-2028)
10.2 South America Anti-PD-1 Antibody Sales by Application (2017-2028)
10.3 South America Anti-PD-1 Antibody Market Size by Country
10.3.1 South America Anti-PD-1 Antibody Sales in Volume by Country (2017-2028)
10.3.2 South America Anti-PD-1 Antibody Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-PD-1 Antibody Sales by Type (2017-2028)
11.2 Middle East & Africa Anti-PD-1 Antibody Sales by Application (2017-2028)
11.3 Middle East & Africa Anti-PD-1 Antibody Market Size by Country
11.3.1 Middle East & Africa Anti-PD-1 Antibody Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anti-PD-1 Antibody Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anti-PD-1 Antibody and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anti-PD-1 Antibody
12.3 Anti-PD-1 Antibody Production Process
12.4 Anti-PD-1 Antibody Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anti-PD-1 Antibody Typical Distributors
13.3 Anti-PD-1 Antibody Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Anti-PD-1 Antibody Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Anti-PD-1 Antibody Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bio X Cell Basic Information, Manufacturing Base and Competitors
Table 4. Bio X Cell Major Business
Table 5. Bio X Cell Anti-PD-1 Antibody Product and Services
Table 6. Bio X Cell Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 8. Thermo Fisher Major Business
Table 9. Thermo Fisher Anti-PD-1 Antibody Product and Services
Table 10. Thermo Fisher Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. InvivoGen Basic Information, Manufacturing Base and Competitors
Table 12. InvivoGen Major Business
Table 13. InvivoGen Anti-PD-1 Antibody Product and Services
Table 14. InvivoGen Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. BioVision Inc Basic Information, Manufacturing Base and Competitors
Table 16. BioVision Inc Major Business
Table 17. BioVision Inc Anti-PD-1 Antibody Product and Services
Table 18. BioVision Inc Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Abcam Basic Information, Manufacturing Base and Competitors
Table 20. Abcam Major Business
Table 21. Abcam Anti-PD-1 Antibody Product and Services
Table 22. Abcam Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bristol-Myers Squibb (BMS) Basic Information, Manufacturing Base and Competitors
Table 24. Bristol-Myers Squibb (BMS) Major Business
Table 25. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product and Services
Table 26. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck Basic Information, Manufacturing Base and Competitors
Table 28. Merck Major Business
Table 29. Merck Anti-PD-1 Antibody Product and Services
Table 30. Merck Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Ono Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Ono Pharmaceutical Co., Ltd Major Business
Table 33. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product and Services
Table 34. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Lilly Basic Information, Manufacturing Base and Competitors
Table 36. Lilly Major Business
Table 37. Lilly Anti-PD-1 Antibody Product and Services
Table 38. Lilly Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Chugai Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 40. Chugai Pharmaceutical Co., Ltd Major Business
Table 41. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product and Services
Table 42. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. BeiGene Basic Information, Manufacturing Base and Competitors
Table 44. BeiGene Major Business
Table 45. BeiGene Anti-PD-1 Antibody Product and Services
Table 46. BeiGene Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Abbvie Basic Information, Manufacturing Base and Competitors
Table 48. Abbvie Major Business
Table 49. Abbvie Anti-PD-1 Antibody Product and Services
Table 50. Abbvie Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. TG Therapeutics, Inc Basic Information, Manufacturing Base and Competitors
Table 52. TG Therapeutics, Inc Major Business
Table 53. TG Therapeutics, Inc Anti-PD-1 Antibody Product and Services
Table 54. TG Therapeutics, Inc Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Novartis Basic Information, Manufacturing Base and Competitors
Table 56. Novartis Major Business
Table 57. Novartis Anti-PD-1 Antibody Product and Services
Table 58. Novartis Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Arcus Biosciences Basic Information, Manufacturing Base and Competitors
Table 60. Arcus Biosciences Major Business
Table 61. Arcus Biosciences Anti-PD-1 Antibody Product and Services
Table 62. Arcus Biosciences Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Sino Biological Inc Basic Information, Manufacturing Base and Competitors
Table 64. Sino Biological Inc Major Business
Table 65. Sino Biological Inc Anti-PD-1 Antibody Product and Services
Table 66. Sino Biological Inc Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. 3SBio Inc Basic Information, Manufacturing Base and Competitors
Table 68. 3SBio Inc Major Business
Table 69. 3SBio Inc Anti-PD-1 Antibody Product and Services
Table 70. 3SBio Inc Anti-PD-1 Antibody Sales (Kg), Price (USD/g), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Global Anti-PD-1 Antibody Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kg)
Table 72. Global Anti-PD-1 Antibody Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 73. Market Position of Manufacturers in Anti-PD-1 Antibody, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 74. Global Anti-PD-1 Antibody Production Capacity by Company, (Kg): 2020 VS 2021
Table 75. Head Office and Anti-PD-1 Antibody Production Site of Key Manufacturer
Table 76. Anti-PD-1 Antibody New Entrant and Capacity Expansion Plans
Table 77. Anti-PD-1 Antibody Mergers & Acquisitions in the Past Five Years
Table 78. Global Anti-PD-1 Antibody Sales by Region (2017-2022) & (Kg)
Table 79. Global Anti-PD-1 Antibody Sales by Region (2023-2028) & (Kg)
Table 80. Global Anti-PD-1 Antibody Revenue by Region (2017-2022) & (USD Million)
Table 81. Global Anti-PD-1 Antibody Revenue by Region (2023-2028) & (USD Million)
Table 82. Global Anti-PD-1 Antibody Sales by Type (2017-2022) & (Kg)
Table 83. Global Anti-PD-1 Antibody Sales by Type (2023-2028) & (Kg)
Table 84. Global Anti-PD-1 Antibody Revenue by Type (2017-2022) & (USD Million)
Table 85. Global Anti-PD-1 Antibody Revenue by Type (2023-2028) & (USD Million)
Table 86. Global Anti-PD-1 Antibody Price by Type (2017-2022) & (USD/g)
Table 87. Global Anti-PD-1 Antibody Price by Type (2023-2028) & (USD/g)
Table 88. Global Anti-PD-1 Antibody Sales by Application (2017-2022) & (Kg)
Table 89. Global Anti-PD-1 Antibody Sales by Application (2023-2028) & (Kg)
Table 90. Global Anti-PD-1 Antibody Revenue by Application (2017-2022) & (USD Million)
Table 91. Global Anti-PD-1 Antibody Revenue by Application (2023-2028) & (USD Million)
Table 92. Global Anti-PD-1 Antibody Price by Application (2017-2022) & (USD/g)
Table 93. Global Anti-PD-1 Antibody Price by Application (2023-2028) & (USD/g)
Table 94. North America Anti-PD-1 Antibody Sales by Country (2017-2022) & (Kg)
Table 95. North America Anti-PD-1 Antibody Sales by Country (2023-2028) & (Kg)
Table 96. North America Anti-PD-1 Antibody Revenue by Country (2017-2022) & (USD Million)
Table 97. North America Anti-PD-1 Antibody Revenue by Country (2023-2028) & (USD Million)
Table 98. North America Anti-PD-1 Antibody Sales by Type (2017-2022) & (Kg)
Table 99. North America Anti-PD-1 Antibody Sales by Type (2023-2028) & (Kg)
Table 100. North America Anti-PD-1 Antibody Sales by Application (2017-2022) & (Kg)
Table 101. North America Anti-PD-1 Antibody Sales by Application (2023-2028) & (Kg)
Table 102. Europe Anti-PD-1 Antibody Sales by Country (2017-2022) & (Kg)
Table 103. Europe Anti-PD-1 Antibody Sales by Country (2023-2028) & (Kg)
Table 104. Europe Anti-PD-1 Antibody Revenue by Country (2017-2022) & (USD Million)
Table 105. Europe Anti-PD-1 Antibody Revenue by Country (2023-2028) & (USD Million)
Table 106. Europe Anti-PD-1 Antibody Sales by Type (2017-2022) & (Kg)
Table 107. Europe Anti-PD-1 Antibody Sales by Type (2023-2028) & (Kg)
Table 108. Europe Anti-PD-1 Antibody Sales by Application (2017-2022) & (Kg)
Table 109. Europe Anti-PD-1 Antibody Sales by Application (2023-2028) & (Kg)
Table 110. Asia-Pacific Anti-PD-1 Antibody Sales by Region (2017-2022) & (Kg)
Table 111. Asia-Pacific Anti-PD-1 Antibody Sales by Region (2023-2028) & (Kg)
Table 112. Asia-Pacific Anti-PD-1 Antibody Revenue by Region (2017-2022) & (USD Million)
Table 113. Asia-Pacific Anti-PD-1 Antibody Revenue by Region (2023-2028) & (USD Million)
Table 114. Asia-Pacific Anti-PD-1 Antibody Sales by Type (2017-2022) & (Kg)
Table 115. Asia-Pacific Anti-PD-1 Antibody Sales by Type (2023-2028) & (Kg)
Table 116. Asia-Pacific Anti-PD-1 Antibody Sales by Application (2017-2022) & (Kg)
Table 117. Asia-Pacific Anti-PD-1 Antibody Sales by Application (2023-2028) & (Kg)
Table 118. South America Anti-PD-1 Antibody Sales by Country (2017-2022) & (Kg)
Table 119. South America Anti-PD-1 Antibody Sales by Country (2023-2028) & (Kg)
Table 120. South America Anti-PD-1 Antibody Revenue by Country (2017-2022) & (USD Million)
Table 121. South America Anti-PD-1 Antibody Revenue by Country (2023-2028) & (USD Million)
Table 122. South America Anti-PD-1 Antibody Sales by Type (2017-2022) & (Kg)
Table 123. South America Anti-PD-1 Antibody Sales by Type (2023-2028) & (Kg)
Table 124. South America Anti-PD-1 Antibody Sales by Application (2017-2022) & (Kg)
Table 125. South America Anti-PD-1 Antibody Sales by Application (2023-2028) & (Kg)
Table 126. Middle East & Africa Anti-PD-1 Antibody Sales by Region (2017-2022) & (Kg)
Table 127. Middle East & Africa Anti-PD-1 Antibody Sales by Region (2023-2028) & (Kg)
Table 128. Middle East & Africa Anti-PD-1 Antibody Revenue by Region (2017-2022) & (USD Million)
Table 129. Middle East & Africa Anti-PD-1 Antibody Revenue by Region (2023-2028) & (USD Million)
Table 130. Middle East & Africa Anti-PD-1 Antibody Sales by Type (2017-2022) & (Kg)
Table 131. Middle East & Africa Anti-PD-1 Antibody Sales by Type (2023-2028) & (Kg)
Table 132. Middle East & Africa Anti-PD-1 Antibody Sales by Application (2017-2022) & (Kg)
Table 133. Middle East & Africa Anti-PD-1 Antibody Sales by Application (2023-2028) & (Kg)
Table 134. Anti-PD-1 Antibody Raw Material
Table 135. Key Manufacturers of Anti-PD-1 Antibody Raw Materials
Table 136. Direct Channel Pros & Cons
Table 137. Indirect Channel Pros & Cons
Table 138. Anti-PD-1 Antibody Typical Distributors
Table 139. Anti-PD-1 Antibody Typical Customers
List of Figures
Figure 1. Anti-PD-1 Antibody Picture
Figure 2. Global Anti-PD-1 Antibody Revenue Market Share by Type in 2021
Figure 3. Monoclonal
Figure 4. Polyclonal
Figure 5. Global Anti-PD-1 Antibody Revenue Market Share by Application in 2021
Figure 6. IHC-P
Figure 7. ICC/IF
Figure 8. WB
Figure 9. Flow Cytometry
Figure 10. ELISA
Figure 11. Global Anti-PD-1 Antibody Revenue, (USD Million) & (Kg): 2017 & 2021 & 2028
Figure 12. Global Anti-PD-1 Antibody Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Anti-PD-1 Antibody Sales (2017-2028) & (Kg)
Figure 14. Global Anti-PD-1 Antibody Price (2017-2028) & (USD/g)
Figure 15. Global Anti-PD-1 Antibody Production Capacity (2017-2028) & (Kg)
Figure 16. Global Anti-PD-1 Antibody Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Anti-PD-1 Antibody Market Drivers
Figure 18. Anti-PD-1 Antibody Market Restraints
Figure 19. Anti-PD-1 Antibody Market Trends
Figure 20. Global Anti-PD-1 Antibody Sales Market Share by Manufacturer in 2021
Figure 21. Global Anti-PD-1 Antibody Revenue Market Share by Manufacturer in 2021
Figure 22. Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Anti-PD-1 Antibody Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Anti-PD-1 Antibody Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Anti-PD-1 Antibody Sales Market Share by Region (2017-2028)
Figure 26. Global Anti-PD-1 Antibody Revenue Market Share by Region (2017-2028)
Figure 27. North America Anti-PD-1 Antibody Revenue (2017-2028) & (USD Million)
Figure 28. Europe Anti-PD-1 Antibody Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Anti-PD-1 Antibody Revenue (2017-2028) & (USD Million)
Figure 30. South America Anti-PD-1 Antibody Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Anti-PD-1 Antibody Revenue (2017-2028) & (USD Million)
Figure 32. Global Anti-PD-1 Antibody Sales Market Share by Type (2017-2028)
Figure 33. Global Anti-PD-1 Antibody Revenue Market Share by Type (2017-2028)
Figure 34. Global Anti-PD-1 Antibody Price by Type (2017-2028) & (USD/g)
Figure 35. Global Anti-PD-1 Antibody Sales Market Share by Application (2017-2028)
Figure 36. Global Anti-PD-1 Antibody Revenue Market Share by Application (2017-2028)
Figure 37. Global Anti-PD-1 Antibody Price by Application (2017-2028) & (USD/g)
Figure 38. North America Anti-PD-1 Antibody Sales Market Share by Type (2017-2028)
Figure 39. North America Anti-PD-1 Antibody Sales Market Share by Application (2017-2028)
Figure 40. North America Anti-PD-1 Antibody Sales Market Share by Country (2017-2028)
Figure 41. North America Anti-PD-1 Antibody Revenue Market Share by Country (2017-2028)
Figure 42. United States Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Anti-PD-1 Antibody Sales Market Share by Type (2017-2028)
Figure 46. Europe Anti-PD-1 Antibody Sales Market Share by Application (2017-2028)
Figure 47. Europe Anti-PD-1 Antibody Sales Market Share by Country (2017-2028)
Figure 48. Europe Anti-PD-1 Antibody Revenue Market Share by Country (2017-2028)
Figure 49. Germany Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Anti-PD-1 Antibody Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Anti-PD-1 Antibody Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Anti-PD-1 Antibody Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Anti-PD-1 Antibody Revenue Market Share by Region (2017-2028)
Figure 58. China Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Anti-PD-1 Antibody Sales Market Share by Type (2017-2028)
Figure 65. South America Anti-PD-1 Antibody Sales Market Share by Application (2017-2028)
Figure 66. South America Anti-PD-1 Antibody Sales Market Share by Country (2017-2028)
Figure 67. South America Anti-PD-1 Antibody Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Anti-PD-1 Antibody Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Anti-PD-1 Antibody Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Anti-PD-1 Antibody Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Anti-PD-1 Antibody Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Anti-PD-1 Antibody Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Anti-PD-1 Antibody in 2021
Figure 79. Manufacturing Process Analysis of Anti-PD-1 Antibody
Figure 80. Anti-PD-1 Antibody Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
